Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib Dose Escalation in Metastatic Renal Cell Carcinoma
NCT00445042Phase 2Completed
- Sponsor
- Houston Methodist Research Institute
- Start
- Nov 2005
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in renal cell carcinoma (RCC), sponsored by Houston Methodist Research Institute. Started Nov 2005; status: completed.
02
Drugs
sorafenib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00445042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00445042.